Online Media Kit


January 26, 2021 | World Health Organization

WHO recommends the dapivirine vaginal ring as a new choice for HIV prevention for women at substantial risk of HIV infection

WHO recommended that the dapivirine vaginal ring, a female-initiated option to reduce the risk of HIV infection, may be offered as an additional prevention choice for women at substantial HIV risk as... More »


November 30, 2020 | New York Times

Berry-Flavored H.I.V. Medication Is Ready for Babies

The World Health Organization approved the dapivirine ring, a vaginal insert that has proved effective in women who use it consistently. Finding prevention methods that women can use discreetly has... More »


July 30, 2020 | Aidsmap (UK)

The vaginal ring against HIV: regulatory approval for a new prevention choice for women

The dapivirine ring is the first HIV prevention option specifically designed for women since the female condom was approved nearly 30 years ago. More »


July 24, 2020 | Times LIVE (South Africa)

Vaginal ring gives women more options for HIV prevention

Access to a long-acting vaginal ring, which was tested in SA and showed promising results, is getting closer to reality after Europe’s regulatory body gave it the thumbs-up. More »

Media Highlights

July 27, 2020 | The Star (Kenya)

Vaginal ring: New PrEP option to support women's fight against HIV

The ring is made of a flexible silicon matrix polymer and contains ARV dapivirine which is slowly released over the course of the month. It is to be used by women aged above 18 years. More »

July 27, 2020 | SABC News (South Africa)

Vaginal ring a step closer to becoming new HIV prevention method

This comes after Europe’s regulatory body gave the dapivirine vaginal ring the green light. The vaginal ring has showed that it reduces chances of HIV transmission by 35% in women. More »

July 27, 2020 | Radio Jambo (Kenya)

Je,kifaa hiki kitawazuia wanawake kuambukizwa HIV?

Women who are at risk of contracting HIV will now be able to get help through a new ring that they insert into their vagina to prevent infection. More »

July 27, 2020 | PharmaTimes

Eleven medicines backed for EU approval

The Dapivirine Vaginal Ring, developed by IPM Belgium to reduce the risk of infection with HIV-1 in combination with safer sex practices when oral PrEP is not used, is the eleventh medicine... More »

July 27, 2020 | 의학신문 (South Korea)

유럽 3개 신약 승인권고

CHMP recommended Dapivirine vaginal rings to reduce the risk of HIV-1 infection, so that they can be used when prophylaxis before oral exposure is not available. More »